Willem Lybaert

Az Klina
Brasschaat, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Az Klina
Brasschaat, VLG, BE 

Overview

Willem Lybaert practices practicing medicine in Brasschaat, Belgium.

His clinical expertise encompasses Neuroendocrine Tumor, Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Cancer, and Salivary Gland Tumors.

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

AZ KLINA
Brasschaat, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer
ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Abiraterone, Carboplatin, Cabazitaxel, Docetaxel, Radium Chloride Ra-223
Study Phase: Phase 3
An Open Label Multi-Center Study of the Effects of GC4419 When Administered to Reduce the Incidence and Severity of Severe Oral Mucositis Associated With Chemo RT for Locally Advanced, Non-Metastatic Head and Neck Cancer
An Open Label Multi-Center Study of the Effects of GC4419 When Administered to Reduce the Incidence and Severity of Severe Oral Mucositis Associated With Chemo RT for Locally Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug, Radiation
Study Drug: GC4419
Study Phase: Phase 2
View 1 Less Clinical Trial

35 Total Publications

Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12-year retrospective analysis within NETwerk, an ENETS center of excellence.
Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12-year retrospective analysis within NETwerk, an ENETS center of excellence.
Journal: Journal of neuroendocrinology
Published: March 19, 2026

Frequently Asked Questions about Willem Lybaert

Is Willem Lybaert a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Willem Lybaert is classified as an Experienced expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Willem Lybaert participate in research or clinical trials?

Yes. Willem Lybaert has published 35 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Willem Lybaert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lybaert's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile